NetworkNewsBreaks

WednesdayMay 26, 2021 12:35 pm

NetworkNewsBreaks – Music DeFi Pioneer BAND Royalty Featured in NNW Editorial

BAND Royalty today announced its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. The publication, titled, “NFTs Flipping the Script, Bringing Value Back to Music Artists,” discusses the recent emergence of NFTs, or non-fungible tokens, which are breathing life into the industry as musicians get creative with ways to generate revenue and better connect with fans. “An NFT is, in essence, a collectible digital asset, which holds value as a form of cryptocurrency and as a form of art…

Continue Reading

WednesdayMay 26, 2021 12:24 pm

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder, CEO Authors Book Focused on Groundbreaking Work

Vivos Therapeutics (NASDAQ: VVOS) founder and chief medical officer, Dr. G. Dave Singh, DMD, PhD, DDSc, has written a new book with the intent of assisting doctors and dentists in better understanding how to address underlying craniofacial conditions that impact a patient’s overall airway, breathing and sleep health. Titled “Pneumopedics and Craniofacial Epigenetics,” the book covers craniofacial growth and developmental genetics, and addresses the connection between dentofacial anomalies and developmental deficiencies closely associated with downstream conditions such as obstructive sleep apnea (“OSA”). In addition, the book, which is available on Amazon, solidifies the scientific and biological foundation upon which VVOS’s proprietary approach…

Continue Reading

WednesdayMay 26, 2021 12:09 pm

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Initiation of PALISADE Phase 3 Study of PH94B in SAD

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, is beginning its PALISADE-1 phase 3 trial. The randomized, double-blind, placebo-controlled study is designed to evaluate the efficacy and safety of VTGN’s PH94B (“PH94B”) for the treatment of anxiety in adults with Social Anxiety Disorder (“SAD”). In the announcement, the company noted there is no FDA-approved acute treatment for the disorder. The company plans to include some 200 randomized subjects in the study, which…

Continue Reading

WednesdayMay 26, 2021 11:03 am

NetworkNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Acquisition of The Lodge Winery & Olive Oil Co.

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the acquisition of The Lodge Winery & Olive Oil Co. under GTV’s Food & Wine Division, Napa Wine Brands Inc. The Lodge Winery & Olive Oil Co. is an established brand that produces award-winning wines, locally grown and milled, single varietal extra virgin olive oils, as well as a variety of award-winning wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “We…

Continue Reading

WednesdayMay 26, 2021 10:23 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces PCT Filing, Bringing Potential to Obtain Patent Coverage in 153 Countries

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed an international patent application that further strengthens its psychedelic derivative drug development candidates across 153 global jurisdictions. Per the update, the application, governed by the Patent Cooperation Treaty (“PCT”), grants Cybin the right to file future national applications into treaty member jurisdictions, including important potential markets for the company. The PCT claims a library of psychedelic derivative drug development candidates. “Technologies gained by Cybin resulting from our strategic acquisition of Adelia Therapeutics, coupled with subsequent research initiatives from our experienced scientific…

Continue Reading

WednesdayMay 26, 2021 9:59 am

NetworkNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Commences Drilling at Idaho-Based Oakley Project

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced the commencement of a 2,800-metre diamond drilling program at the Oakley Project, Idaho in collaboration with Centerra (U.S.) Inc. According to the update, Centerra has the option to earn up to a 70% interest in the project by, among other things, spending up to US$7 million in exploration expenditures prior to May 2026. Under the terms of the option agreement between the parties, Excellon is the manager of the project and Centerra is the operator and currently funds all expenditures. "Oakley is a low-sulphidation, epithermal gold project with the…

Continue Reading

WednesdayMay 26, 2021 9:32 am

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Releases Q1 2021 Financial Numbers, Chooses SRAX Inc. (NASDAQ: SRAX) as Communications Partner

Grapefruit USA (OTCQB: GPFT), a California-based cannabis company, has partnered with SRAX Inc. (NASDAQ: SRAX), an investor relations and communications marketing firm, to strengthen its brand and product line as well as increase awareness of its new e-commerce site and related affiliate program. In the announcement Grapefruit cited SRAX’s novel data-driven approaches to marketing and the company ability to create awareness of stock as key factors in its decision. In addition, the company has filed its quarterly report for the period ended March 31, 2021. The report included disappointing numbers for the company, including net revenues of $350,815, a decrease of…

Continue Reading

TuesdayMay 25, 2021 2:48 pm

NetworkNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) President Looks to Transformative Potential of AR

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services for e-commerce, education, advertising, conferences and events, is poised to continue growing through the coming years thanks to the disruptive capabilities of AR. A 2017 Harvard Business Review article projected that AR, which at that time was in its infancy, would soon become mainstream and transform various industries. In a podcast interview with Oren Klaff, Nextech president Paul Duffy also gave a positive outlook for the AR market. A recent article quoted him as saying, “The whole concept of…

Continue Reading

TuesdayMay 25, 2021 2:37 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Strengthening Partnerships with China Telecom Giants

FingerMotion (OTCQX: FNGR), an evolving technology company, is one of only a handful of companies in China with access to wholesale rechargeable minutes from China’s largest mobile phone providers — China Mobile, China Telecom and China Unicom — that can be resold to consumers. By constantly evolving its core competencies in mobile payment and recharge platform solutions in mainland China, FNGR has positioned itself to capitalize on the growth of the telecom market and its relationships with telecommunication companies. According to a recent article, FNGR “is currently working to strengthen the existing and strategic partnerships it has with Chinese telecommunication…

Continue Reading

TuesdayMay 25, 2021 1:54 pm

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Able to Fully Fund Physical Uranium Initiative

Uranium Energy (NYSE American: UEC), a Texas-based uranium mining and exploration company, was the subject of a recent research report by H.C. Wainwright & Co. (“Wainwright”). The analysts reiterated a buy rating for UEC’s stock, which, as they project, would reach a price target of $5. According to an article reporting the matter, the price projection and the buy rating are “based on a discounted cash flow (‘DCF’) model of future operations and in situ asset values.” Wainwright used a revised discount rate of 7.5%, as well as the value of assets, including Reno Creek ($75.0M), Alto Parana ($41.5M), Paraguay…

Continue Reading